1
|
PAX8 Expression in Solitary Fibrous Tumor: A Potential Diagnostic Pitfall. Appl Immunohistochem Mol Morphol 2019; 27:195-202. [DOI: 10.1097/pai.0000000000000561] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
2
|
Solitary fibrous tumor of the abdominal wall re-surfacing as unilateral pleural effusion and mass: A case report and review of the literature. Respir Med Case Rep 2017; 23:4-7. [PMID: 29159031 PMCID: PMC5683803 DOI: 10.1016/j.rmcr.2017.10.013] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/27/2017] [Revised: 10/30/2017] [Accepted: 10/30/2017] [Indexed: 12/11/2022] Open
Abstract
Background Solitary fibrous tumors (SFTs) are rare fibroblastic mesenchymal neoplasms that were initially described in the pleura, but have been increasingly recognized to occur in other parts of the body. They have been traditionally regarded as indolent tumors that are rare to metastasize after surgical resection. Here, we describe a case of a Filipino female who initially presented with unilateral pleural effusion and mass, and was ultimately diagnosed with recurrent solitary fibrous tumor that originated from the abdominal wall. Then, we reviewed existing literature on intra- and extrathoracic SFTs with focus on pathological characteristics, recommendations for treatment as well as post-treatment surveillance. Case presentation A 79-year-old Filipino female with a history of solitary fibrous tumor of the abdominal wall status post complete surgical resection 3 years ago presented with unilateral pleural effusion and mass, and was diagnosed with recurrent solitary fibrous tumor that metastasized to the lung. She was not a candidate for systemic chemotherapy and ultimately died 1 year later from progressive respiratory failure. Conclusions Solitary fibrous tumor are rare mesenchymal tumors that were initially described in the pleura, but have now been reported in many other sites. Complete surgical resection is the mainstay therapy for all cases; however, long-term monitoring and surveillance several years after initial presentation is crucial to prevent disease recurrence, and adjuvant treatment may be necessary for patients with high-risk features. Additional studies are needed to demonstrate the clinical utility of risk stratification models and to develop post-treatment surveillance guidelines for extrathoracic SFTs.
Collapse
|
3
|
Maki T, Fujino S, Misu K, Kaneko H, Inomata H, Omi M, Tateno M, Nihei K. Integrally calcified solitary fibrous tumor in the retroperitoneum: a case report and review of the literature. Surg Case Rep 2016; 2:14. [PMID: 26943690 PMCID: PMC4752942 DOI: 10.1186/s40792-016-0143-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2015] [Accepted: 02/11/2016] [Indexed: 12/12/2022] Open
Abstract
Solitary fibrous tumor (SFT) is a rare stromal neoplasm and usually occurs in the thoracic cavity. We here report a case of retroperitoneal SFT with prominent calcification. A 64-year-old man presented with an incidentally detected retroperitoneal mass in the right upper abdomen. Imaging tests indicated an integrally calcified mass. The lesion was observed for 2 years and laparoscopically resected according to the patient's wish. Microscopically, the mass was mostly occupied by calcification and proliferous spindle cells were scattered with positive CD34 expression. We diagnosed morphologically benign SFT and the patient remained disease-free 1 year after the excision. There has been no report of such integrally calcified SFT. Retroperitoneal SFT is difficult to make a preoperative diagnosis, and careful follow-up after the excision is recommended because morphological malignancy does not always correspond to clinical malignancy.
Collapse
Affiliation(s)
- Takehiro Maki
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Syotaro Fujino
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Kenjiro Misu
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Hiroyuki Kaneko
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Hitoshi Inomata
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Makoto Omi
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Masatoshi Tateno
- Department of Pathology, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| | - Kazuyoshi Nihei
- Department of Surgery, Kushiro Red Cross Hospital, 21-14, Shineichyo, Kushiro, Hokkaido, 085-8512, Japan.
| |
Collapse
|